Other safety alerts
|
| |
| Canada: Unauthorized prescription product “Kobayashi Aibon/Eyebon Eyewash” seized from Tokyo Beauty & Health Care in Richmond, B.C., may pose serious health risks |
| |
Health Canada is advising consumers that the unauthorized product "Kobayashi Aibon/Eyebon Eyewash" is labelled to contain a prescription drug (aminocaproic acid) and may pose serious health risks. The product is promoted as an eyewash for contact lens users and for the prevention of eye disease.
Products affected are namely Kobayashi Aibon/Eyebon Eyewash - Cool format and Kobayashi Aibon/Eyebon Eyewash - Mild format. Health Canada seized two formats, "Cool" and "Mild," from a Tokyo Beauty & Health Care retail location in Richmond, British Columbia (120 - 8191 Westminster Highway).
The unauthorized health product was packaged and labelled in Japanese ("Eyebon" may also be translated as "Aibon"). As a result, information about ingredients, usage, dosage and side effects may not be understood by all consumers.
Aminocaproic acid is a prescription drug ingredient used to decrease bleeding in various clinical situations. Exposure to aminocaproic acid in the eye may affect the eye itself, and the acid may be absorbed through the tear ducts into the blood. Side effects may include watery eyes, vision changes, headache, dizziness, nausea, muscle weakness, and skin rash.
Consumers are advised to stop using this product and consult health care professional if they have used this product and have health concerns.
Please refer to the following webiste in Health Canada for details:
http://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/../69082a-eng.php
In Hong Kong, the above products are not registered pharmaceutical products. Related news on ‘Kobayashi Eyebon Eyewash’ has been previously issued by Health Canada, and was posted on the Drug Office website on 29 August 2017.
Ends/ Saturday, Feb 16, 2019
Issued at HKT 14:30
|
| |
|
